Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet‐derived growth factor‐A
- 1 January 2000
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 8 (1) , 26-35
Abstract
Gene therapy promises the potential for improved treatment of cutaneous wounds. This study evaluated whether genetically modified cultured skin substitutes can act as vehicles for gene therapy in an athymic mouse model of wound healing. Human keratinocytes and fibroblasts were genetically engineered by retroviral transduction to overexpress human platelet‐derived growth factor‐A chain. Three types of skin substitutes were prepared from collagen‐glycosaminoglycan substrates populated with fibroblasts and keratinocytes: HF–/HK–, containing both unmodified fibroblasts and keratinocytes; HF–/HK+, containing unmodified fibroblasts and modified keratinocytes; and HF+/HK–, containing modified fibroblasts and unmodified keratinocytes. Skin substitutes were cultured for two weeks before grafting to full‐thickness wounds on athymic mice. The modified skin substitutes secreted significantly elevated levels of platelet‐derived growth factor throughout the culture period. Expression of retroviral platelet‐derived growth factor‐A mRNA was maintained after grafting to mice, and was detected in all HF–/HK+ grafts and one HF+/HK– graft at two weeks after surgery. Although no differences were seen between control and modified grafts, the results suggest that genetically modified cultured skin substitutes can be a feasible mechanism for cutaneous gene therapy. The cultured skin model used for these studies has advantages over other skin analogs containing only epidermal cells; because it contains both fibroblasts and keratinocytes, it therefore offers greater opportunities for genetic modification and potential modulation of wound healing.Keywords
This publication has 18 references indexed in Scilit:
- Adenoviral-Mediated Overexpression of Platelet-Derived Growth Factor-B Corrects Ischemic Impaired Wound HealingJournal of Investigative Dermatology, 1999
- Particle-Mediated Gene Transfer of PDGF Isoforms Promotes Wound RepairJournal of Investigative Dermatology, 1999
- Genetically Modified Human Keratinocytes Overexpressing PDGF-A Enhance the Performance of a Composite Skin GraftHuman Gene Therapy, 1998
- Comparative Assessment of Cultured Skin Substitutes and Native Skin Autograft for Treatment of Full-Thickness BurnsAnnals of Surgery, 1995
- Genetically Modified Human Epidermis Overexpressing PDGF-A Directs the Development of a Cellular and Vascular Connective Tissue Stroma When Transplanted to Athymic Mice–Implications for the Use of Genetically Modified Keratinocytes to Modulate Dermal RegenerationJournal of Investigative Dermatology, 1995
- PDGF and TGF-α Act Synergistically to Improve Wound Healing in the Genetically Diabetic MouseJournal of Surgical Research, 1994
- Human keratinocytes are a major source of cutaneous platelet-derived growth factor.Journal of Clinical Investigation, 1993
- Growth factors and wound healing: Part II. Role in normal and chronic wound healingThe American Journal of Surgery, 1993
- Skin Anatomy and Antigen Expression after Burn Wound Closure with Composite Grafts of Cultured Skin Cells and BiopolymersPlastic and Reconstructive Surgery, 1993
- Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds.Journal of Clinical Investigation, 1989